Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2026 -5.147M
June 30, 2026 3.96M
March 31, 2026 -2.326M
December 31, 2025 -15.33M
September 30, 2025 -0.012M
June 30, 2025 -0.014M
March 31, 2025 1.903M
December 31, 2024 2.635M
September 30, 2024 3.888M
June 30, 2024 -8.793M
March 31, 2024 -0.038M
December 31, 2023 9.742M
September 30, 2023 2.122M
June 30, 2023 19.16M
March 31, 2023 15.43M
December 31, 2022 -5.102M
September 30, 2022 -40.91M
June 30, 2022 -0.097M
March 31, 2022 -0.046M
December 31, 2021 -0.146M
September 30, 2021 -0.068M
June 30, 2021 -0.115M
March 31, 2021 10.07M
December 31, 2020 0.902M
September 30, 2020 0.178M
Date Value
June 30, 2020 6.702M
March 31, 2020 5.256M
December 31, 2019 0.72M
September 30, 2019 13.48M
June 30, 2019 -0.194M
March 31, 2019 2.946M
December 31, 2018 9.784M
September 30, 2018 -0.138M
June 30, 2018 -0.041M
March 31, 2018 2.211M
December 31, 2017 -0.583M
September 30, 2017 -0.258M
June 30, 2017 -0.23M
March 31, 2017 -9.154M
December 31, 2016 -0.409M
September 30, 2016 -0.464M
June 30, 2016 -9.198M
March 31, 2016 -0.818M
December 31, 2015 22.78M
September 30, 2015 -2.027M
June 30, 2015 -2.453M
March 31, 2015 -0.3734M
December 31, 2014 -0.2084M
September 30, 2014 -0.0925M
June 30, 2014 -0.1793M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Curis, Inc. 0.00
Armata Pharmaceuticals, Inc. -0.091M
Voyager Therapeutics, Inc. 29.27M
Black Diamond Therapeutics, Inc. 4.218M
Invivyd, Inc. -0.585M